Drug Shortage Report for RIVA-RANITIDINE 300
| Report ID | 93930 |
| Drug Identification Number | 02247815 |
| Brand name | RIVA-RANITIDINE 300 |
| Common or Proper name | Riva-Ranitidine 300 |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 & 100 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-09-13 |
| Actual start date | 2019-09-13 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2019-09-14 |
| Company comments | Health Canada imposed distribution restriction |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-09-14 | English | Compare |
| v2 | 2019-09-13 | French | Compare |
| v1 | 2019-09-13 | English | Compare |
Showing 1 to 3 of 3